A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency

• Status: Completed
• Trial end date: 2006-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteers with G6PD deficiency who would be willing to donate blood samples.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Walter Reed Army Institute of Research (WRAIR)
• Treatments: Primaquine

Criteria

Inclusion:

• Normal clinical evaluation

• Willing and able to make all scheduled visits

Exclusion:

• pregnant or planning pregnancy

• Have taken any anti-malarial medication in past month

• Positive blood tests for HIV and specific types of hepatitis

• Allergic to primaquine